Allergan Has Tentative Agreement to End Restasis Antitrust Case
Antitrust litigation over an alleged scheme by AbbVie Inc. subsidiary Allergan to delay generic versions of the dry-eye treatment Restasis was put on hold by a federal judge in Brooklyn while the company finalizes a settlement in principle that would bring the dispute to an end.
Residents of assisted living facilities operated by Aegis Senior Communities LLC (Aegis) will share in a settlement fund of $16.25 million awarded as part of a class action settlement approved by the United States District Court for the Northern District of California on August 23, 2021.
Pursuant to the Settlement Agreement, the Defendant has agreed to pay a gross Dlass Settlement Fund of $1.9 million in cash, in exchange for customary releases.
Several Lloyd’s of London syndicates have agreed to pay $22 million to settle class claims they were conspiring with insurance brokers to conceal exorbitant commissions and the anti-competitive nature of their market, according to a filing Friday in New Jersey federal court.